De-escalating indications for excision when breast core needle biopsy returns fibroepithelial lesion—not further characterized
Breast Cancer Research and Treatment · 2024
DOI: 10.1007/s10549-024-07378-8 ↗Kurz gefasst
Fachartikel in der Zeitschrift Breast Cancer Research and Treatment, 2024. Verfasst von Tahereh Soleimani und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery, Johns Hopkins University School of Medicine, Baltimore, MD, USA. Hauptthemen laut MEDLINE: Breast Neoplasms, Phyllodes Tumor. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 25 Literaturangaben.
Abstract (Originalsprache)
PURPOSE: Surgical excision is often performed to exclude phyllodes tumor (PT) when Core Needle Biopsy (CNB) of the breast returns fibroepithelial lesion-not further characterized (FEL-NFC). If imaging or CNB pathology features can be identified that predict a very low probability of borderline/malignant PT, thousands of women could be spared the expense and morbidity of surgical excisions. METHODS: This retrospective cohort study includes 180 FEL-NFC from 164 patients who underwent surgical excisional biopsy. RESULTS: The upgrade rate from FEL-NFC to benign PT was 15%, and to borderline/malignant PT 7%. Imaging features predicting upgrade to borderline/malignant PT included greater size (p = 0.0002) and heterogeneous echo pattern on sonography (p = 0.117). Histologic features of CNB predicting upgrade to borderline/malignant PT included "pathologist favors PT" (p = 0.012), mitoses (p = 0.014), stromal overgrowth (p = 0.006), increased cellularity (p = 0.0001) and leaf-like architecture (p = 0.077). A three-component score including size > 4.5 cm (Size), heterogeneous echo pattern on sonography (Heterogeneity), and stromal overgrowth on CNB (Overgrowth) maximized the product of sensitivity x specificity for the prediction of borderline/malignant PT. When the SHO score was 0 (72% of FEL-NFC) the probability of borderline/malignant PT on excision was only 1%. CONCLUSION: The combination of size ≤ 4.5 cm, homogeneous echo pattern, and absence of stromal overgrowth is highly predictive of a benign excision potentially sparing most patients diagnosed with FEL-NFC the expense and morbidity of a surgical excision.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Surgery, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
- Currently University of Indiana, Indianapolis, IN, USA.
- Department of Surgery, Johns Hopkins University School of Medicine, Baltimore, MD, USA. deuhus1@jhmi.edu.
- , Fernandina Beach, FL, 32034, USA. deuhus1@jhmi.edu.
- Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
- Howard University, Washington, DC, USA.
ORCID-Profile: David Euhus
Zitieren
APA
Soleimani, T., Euhus, D., Sogunro, O., Cope, L., Janjua, M., Vasigh, M., & Jacobs, L. K. (2024). De-escalating indications for excision when breast core needle biopsy returns fibroepithelial lesion—not further characterized. Breast Cancer Research and Treatment. https://doi.org/10.1007/s10549-024-07378-8
Vancouver
Soleimani T, Euhus D, Sogunro O, Cope L, Janjua M, Vasigh M, et al. De-escalating indications for excision when breast core needle biopsy returns fibroepithelial lesion—not further characterized. Breast Cancer Research and Treatment. 2024. doi:10.1007/s10549-024-07378-8
BibTeX
@article{Soleimani2024,
author = {Soleimani, Tahereh and Euhus, David and Sogunro, Olutayo and Cope, Leslie and Janjua, Mahin and Vasigh, Mahtab and Jacobs, Lisa K},
title = {De-escalating indications for excision when breast core needle biopsy returns fibroepithelial lesion—not further characterized},
journal = {Breast Cancer Research and Treatment},
year = {2024},
doi = {10.1007/s10549-024-07378-8}
}
EUVIMED